R. Baum

2.2k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

R. Baum is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology. According to data from OpenAlex, R. Baum has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in R. Baum's work include Radiopharmaceutical Chemistry and Applications (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Medical Imaging Techniques and Applications (3 papers). R. Baum is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Medical Imaging Techniques and Applications (3 papers). R. Baum collaborates with scholars based in Germany, United Kingdom and Netherlands. R. Baum's co-authors include Helen Young, Karl Herholz, O. S. Hoekstra, U. Cremerius, Jan Pruim, Pat Price, Adriaan A. Lammertsma, T. Brümmendorf, Keith S. Heller and Rainer König and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

R. Baum

15 papers receiving 1.4k citations

Hit Papers

Measurement of clinical and subclinical tumour response u... 1999 2026 2008 2017 1999 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
    1999 1.4k citations Helen Young, R. Baum et al. European Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Baum Germany 5 932 552 408 151 148 15 1.4k
O. S. Hoekstra Netherlands 11 1.0k 1.1× 634 1.1× 624 1.5× 327 2.2× 226 1.5× 35 1.9k
Homer Macapinlac United States 10 466 0.5× 370 0.7× 327 0.8× 339 2.2× 78 0.5× 21 1.2k
Pier Carlo Muzzio Italy 19 637 0.7× 691 1.3× 510 1.3× 377 2.5× 103 0.7× 46 1.4k
Cathy M. Mojzisik United States 18 517 0.6× 345 0.6× 582 1.4× 346 2.3× 97 0.7× 39 1.2k
Elaine Johanna Limkin France 12 1.4k 1.5× 578 1.0× 616 1.5× 242 1.6× 145 1.0× 26 1.8k
Nanda C. Krak Netherlands 13 1.0k 1.1× 367 0.7× 341 0.8× 258 1.7× 283 1.9× 22 1.5k
Jean‐Louis Alberini France 27 810 0.9× 501 0.9× 573 1.4× 469 3.1× 407 2.8× 65 1.9k
Dany Grahek France 21 645 0.7× 470 0.9× 235 0.6× 212 1.4× 226 1.5× 61 1.3k
Jianjun Liu China 18 510 0.5× 313 0.6× 317 0.8× 162 1.1× 247 1.7× 68 1.0k
Bernd‐Joachim Krause Germany 11 439 0.5× 935 1.7× 300 0.7× 496 3.3× 73 0.5× 18 1.3k

Countries citing papers authored by R. Baum

Since Specialization
Citations

This map shows the geographic impact of R. Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Baum more than expected).

Fields of papers citing papers by R. Baum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Baum. The network helps show where R. Baum may publish in the future.

Co-authorship network of co-authors of R. Baum

This figure shows the co-authorship network connecting the top 25 collaborators of R. Baum. A scholar is included among the top collaborators of R. Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Baum. R. Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Singh, Abhilash, et al.. (2019). Long-term Nephrotoxicity After PRRT: Mythos or Reality?. Nuklearmedizin - NuclearMedicine. 1 indexed citations
2.
Strosberg, Jonathan, Edward M. Wolin, Matthew H. Kulke, et al.. (2016). NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: Efficacy, safety, QoL results and subgroup analysis. Annals of Oncology. 27. vi137–vi137. 2 indexed citations
3.
Strosberg, Jonathan, Edward M. Wolin, Beth Chasen, et al.. (2016). NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy, Safety, QoL Results and Subgroup Analysis. Endocrine Abstracts. 4 indexed citations
4.
Meckel, Marian, Vojtěch Kubíček, Petr Hermann, et al.. (2015). 68Ga- und 177Lu-markierte Bisphosphonate als Knochenmetastasen-Theranostika. Der Nuklearmediziner. 38(2). 138–144. 2 indexed citations
5.
6.
7.
Griesinger, Frank, Tobias R. Overbeck, Hilmar Dörge, et al.. (2005). Phase II induction therapy with docetaxel and carboplatin in NSCLC IIIA/IIIB: FDG-PET response predicts overall and disease free survival. Journal of Clinical Oncology. 23(16_suppl). 7184–7184. 2 indexed citations
8.
Griesinger, Frank, C.-P. Criée, H. Dalichau, et al.. (2001). Post-induction FDG-PET in NSCLC IIIA and IIIB: Correlation with morphometric tumor response after docetaxel (D)/carboplatin (C) chemotherapy in combination with erythropoietin. European Journal of Cancer. 37. S53–S53. 2 indexed citations
9.
Young, Helen, R. Baum, U. Cremerius, et al.. (1999). Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Journal of Cancer. 35(13). 1773–1782. 1364 indexed citations breakdown →
10.
Baum, R. & T. Brümmendorf. (1998). Radioimmunolocalization of primary and metastatic breast cancer.. PubMed. 42(1). 33–42. 17 indexed citations
11.
Kirchner, Julian, et al.. (1998). Langzeitverlaufs- und Therapiekontrolle eines hepatisch metastasierenden Azinuszellkarzinoms des Pankreas mittels FDG-PET. Nuklearmedizin - NuclearMedicine. 37(5). 187–191. 5 indexed citations
12.
Driever, Pablo Hernáiz, et al.. (1996). Congenital microgastria, growth hormone deficiency and diabetes insipidus. European Journal of Pediatrics. 156(1). 37–40. 7 indexed citations
13.
Maul, F. D., et al.. (1995). Simultaneous determination of myocardial wall thickening and regional EF by PET — preliminary results. Journal of Nuclear Cardiology. 2(2). S117–S117. 1 indexed citations
14.
Hovy, L., et al.. (1995). Intraoperative Metastasen-lokalisation mit einer handgeführten Gammasonde. Nuklearmedizin - NuclearMedicine. 34(4). 161–164. 4 indexed citations
15.
Baum, R., et al.. (1980). [Change of laterality in chorea and hemiballism].. PubMed. 128(5). 385–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O. S. Hoekstra Breakdown of academic impact, for papers by Homer Macapinlac Breakdown of academic impact, for papers by Pier Carlo Muzzio Breakdown of academic impact, for papers by Cathy M. Mojzisik Breakdown of academic impact, for papers by Elaine Johanna Limkin Breakdown of academic impact, for papers by Nanda C. Krak Breakdown of academic impact, for papers by Jean‐Louis Alberini Breakdown of academic impact, for papers by Dany Grahek Breakdown of academic impact, for papers by Jianjun Liu Breakdown of academic impact, for papers by Bernd‐Joachim Krause
Rankless by CCL
2026